Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Long-term U.S. clinical trial results for orlistat reported in Stockholm

Sep. 3, 1997

Pfizer identifies potent cholesterol absorption inhibitors

Sep. 3, 1997

Crinone launched in the U.S.

Sep. 3, 1997

Mayo Clinic, Wyeth-Ayerst plan fen/phen study

Aug. 29, 1997

Review of fenfluramines points to neurotoxicity

Aug. 29, 1997

FDA wants stronger warning labels for fen/phen

Aug. 29, 1997

First regulatory submission filed for Macritonin

Aug. 28, 1997

CURVES study results point in favor of atorvastatin

Aug. 28, 1997

FDA approves nonsurgical treatment for BPH

Aug. 28, 1997

Roche withdraws NDA for orlistat

Aug. 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...